Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.9K
Overview
44.9K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

3.8K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.8K
Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjunct dexamethasone in herpes simplex virus encephalitis - Authors' reply.

The Lancet. Neurology·2026
Same author

Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

A new Patient-Reported Outcome Scale to assess autoimmune Encephalitis: PROSE.

Annals of neurology·2026
Same author

Psychiatric and behavioural sequelae following encephalitis: a systematic review and meta-analysis.

Brain communications·2026
Same author

Encephalitis.

Lancet (London, England)·2026
Same author

Searching for immune correlates in Lassa vaccine development - workshop report.

NPJ vaccines·2026

Related Experiment Video

Updated: Aug 2, 2025

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus
10:21

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus

Published on: December 2, 2012

20.9K

Addressing vaccine-preventable encephalitis in vulnerable populations.

Bernadeth Lyn C Piamonte1, Ava Easton2,3, Greta K Wood3,4

  • 1Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines.

Current Opinion in Neurology
|April 20, 2023
PubMed
Summary

Vaccinations significantly reduce the global burden of encephalitis. Improving vaccine access and education for vulnerable groups is crucial for better health outcomes.

More Related Videos

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

19.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

627

Related Experiment Videos

Last Updated: Aug 2, 2025

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus
10:21

In Vivo Imaging Systems IVIS Detection of a Neuro-Invasive Encephalitic Virus

Published on: December 2, 2012

20.9K
Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
05:51

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain

Published on: July 24, 2016

19.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

627

Area of Science:

  • Neurology
  • Immunology
  • Public Health

Background:

  • Vaccine-preventable encephalitides pose a significant global health challenge.
  • Key examples include Japanese encephalitis, tick-borne encephalitis, measles encephalitis, and rabies encephalitis.

Approach:

  • Reviewing the role of vaccinations in reducing encephalitis burden.
  • Identifying vulnerable populations at risk for vaccine-preventable encephalitis.
  • Assessing current gaps in vaccination strategies, distribution, and public awareness.

Key Points:

  • Vaccinations are critical in mitigating the impact of encephalitis globally.
  • Vulnerable populations include travelers, military personnel, the immunocompromised, and those in endemic areas.
  • Gaps exist in vaccine availability, equitable distribution, surveillance, and public education.

Conclusions:

  • Enhancing vaccination strategies is essential for improving coverage.
  • Addressing identified gaps will lead to better health outcomes for at-risk individuals.
  • Targeted interventions are needed to protect populations susceptible to vaccine-preventable encephalitis.